BGNE - Beigene, Ltd. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - BGNE (1651308)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
85 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-10-16
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$320.00-5,00011,627,4290%-$1,600,000
2020-10-05
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$300.00-5,00011,692,4290%-$1,500,000
2020-10-05
BGNEWu XiaobinPres, GM ChinaS - Sale$300.00-4,0001,297,9150%-$1,200,000
D
2020-10-05
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$299.60-14,000168,415-8%-$4,194,413
D
2020-09-29
BGNEHuang JaneCMO, HematologyS - Sale+OE$280.38-1,500285,583-1%-$420,568
M
2020-09-28
BGNEOyler JohnCEOS - Sale$280.39-54,30356,196,8000%-$15,226,093
2020-09-25
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$280.42-5,00011,757,4290%-$1,402,116
2020-09-25
BGNEWu XiaobinPres, GM ChinaS - Sale$280.35-4,0001,349,9150%-$1,121,406
2020-09-17
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$260.27-5,00011,822,4290%-$1,301,356
2020-09-17
BGNEWu XiaobinPres, GM ChinaS - Sale$260.33-4,0001,401,9150%-$1,041,327
M
2020-09-14
BGNEOyler JohnCEOS - Sale$253.46-81,22856,902,7390%-$20,587,969
D
2020-09-14
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$250.27-14,000168,415-8%-$3,503,764
2020-09-03
BGNEHuang JaneCMO, HematologyS - Sale$233.07-3,128285,583-1%-$729,045
M
2020-08-31
BGNEOyler JohnCEOS - Sale$233.21-61,04257,958,7030%-$14,235,597
D
2020-08-28
BGNEHuang JaneCMO, HematologyS - Sale+OE$242.21-3,000326,247-1%-$726,626
M
2020-08-19
BGNEOyler JohnCEOS - Sale$237.06-92,17758,752,2490%-$21,851,789
M
2020-08-12
BGNEOyler JohnCEOS - Sale$212.71-42,96859,950,5500%-$9,139,562
DM
2020-08-10
BGNEChen Timothy Yung-ChengDirS - Sale+OE$212.92-7,0000-100%-$1,490,460
2020-08-10
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$211.06-4,00011,887,4290%-$844,229
2020-08-05
BGNEOyler JohnCEOS - Sale$223.27-17,25460,509,1340%-$3,852,273
M
2020-08-03
BGNEOyler JohnCEOS - Sale$221.27-40,55960,733,4360%-$8,974,526
D
2020-07-29
BGNEHuang JaneCMO, HematologyS - Sale+OE$209.93-3,000326,247-1%-$629,787
2020-07-22
BGNEOyler JohnCEOS - Sale$238.34-27,74861,260,7030%-$6,613,503
M
2020-07-20
BGNEOyler JohnCEOS - Sale$251.84-55,17561,621,4270%-$13,895,479
2020-07-20
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$251.51-17,00011,940,9890%-$4,275,636
M
2020-07-17
BGNEWu XiaobinPres, GM ChinaS - Sale$249.22-3,3001,440,9270%-$822,422
M
2020-07-13
BGNEWu XiaobinPres, GM ChinaS - Sale$230.00-5,7001,483,8270%-$1,310,998
2020-07-07
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$200.00-6,00012,161,9890%-$1,200,000
D
2020-07-07
BGNEHuang JaneCMO, HematologyS - Sale+OE$200.00-3,921326,247-1%-$784,200
M
2020-07-06
BGNEOyler JohnCEOS - Sale$199.12-53,91462,338,7020%-$10,735,455
2020-07-01
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$190.75-4,84712,239,9890%-$924,572
M
2020-06-29
BGNEOyler JohnCEOS - Sale$191.85-5,25163,039,5840%-$1,007,391
2020-06-29
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale$191.23-300168,4150%-$57,368
DM
2020-06-26
BGNEHuang JaneCMO, HematologyS - Sale+OE$195.73-4,014326,247-1%-$785,647
M
2020-06-22
BGNEOyler JohnCEOS - Sale$185.90-39,73263,107,8470%-$7,385,983
M
2020-06-22
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$184.09-11,00012,303,0000%-$2,024,971
2020-06-10
BGNEOyler JohnCEOS - Sale$175.07-90063,624,3630%-$157,563
2020-06-08
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale$170.84-453116,4280%-$77,391
2020-06-08
BGNEWu XiaobinPres, GM ChinaS - Sale$170.83-2,8001,399,7800%-$478,317
2020-06-08
BGNEHuang JaneCMO, HematologyS - Sale$170.84-631283,4640%-$107,800
2020-06-08
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$170.91-6,00012,446,0000%-$1,025,455
D
2020-05-29
BGNEHuang JaneCMO, HematologyS - Sale+OE$163.86-1,500291,667-1%-$245,784
2020-05-19
BGNEGlazer Donald W.DirS - Sale$169.84-10,0003,497,6780%-$1,698,400
2020-05-01
BGNEOyler JohnCEOS - Sale$141.43-4,63563,636,0630%-$655,537
2020-05-01
BGNEWu XiaobinPres, GM ChinaS - Sale$141.33-7,0241,436,1800%-$992,711
D
2020-04-29
BGNEHuang JaneCMO, HematologyS - Sale+OE$162.30-1,500291,667-1%-$243,450
D
2020-04-16
BGNEHuang JaneCMO, HematologyS - Sale+OE$160.00-1,500291,667-1%-$240,000
2020-03-04
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$157.14-5,00012,524,0000%-$785,681
D
2020-02-18
BGNEHuang JaneCMO, HematologyS - Sale+OE$170.25-1,500291,667-1%-$255,380
D
2020-01-21
BGNEHuang JaneCMO, HematologyS - Sale+OE$170.69-1,500291,667-1%-$256,042
2019-12-17
BGNEOyler JohnCEOS - Sale$160.62-62,25963,696,3180%-$10,000,100
D
2019-12-16
BGNEHuang JaneCMO, HematologyS - Sale+OE$165.14-1,500291,667-1%-$247,710
D
2019-11-18
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$194.34-25,000122,317-17%-$4,858,616
D
2019-11-18
BGNEHuang JaneCMO, HematologyS - Sale+OE$194.49-1,500291,667-1%-$291,740
M
2019-11-14
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$194.63-13,0007,685,0020%-$2,530,198
2019-11-15
BGNEWu XiaobinPres, GM ChinaS - Sale$202.05-1,0001,483,9560%-$202,050
D
2019-11-04
BGNEHuang JaneCMO, HematologyS - Sale+OE$190.46-32,900291,667-10%-$6,266,007
DM
2019-11-04
BGNEChen Timothy Yung-ChengDirS - Sale+OE$189.86-8,0000-100%-$1,518,845
M
2019-11-01
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$180.00-2,00012,758,0000%-$360,000
2019-11-01
BGNEWu XiaobinPres, GM ChinaS - Sale$180.00-1,0001,496,9560%-$180,000
M
2019-09-03
BGNEHuang JaneCMO, HematologyS - Sale$144.03-2,944291,667-1%-$424,030
D
2019-08-23
BGNEChen Timothy Yung-ChengDirS - Sale+OE$144.96-8,6140-100%-$1,248,680
D
2019-08-12
BGNEHuang JaneCMO, HematologyS - Sale+OE$134.74-2,500328,873-1%-$336,855
D
2019-07-29
BGNEHuang JaneCMO, HematologyS - Sale+OE$134.54-10,130328,873-3%-$1,362,896
2019-07-08
BGNEOyler JohnCEOS - Sale$126.87-3,10664,505,6850%-$394,055
2019-06-27
BGNEHuang JaneCMO, HematologyS - Sale$124.52-430328,8730%-$53,542
2019-06-27
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale$9.47-5,876122,317-5%-$55,653
2019-07-01
BGNEWang XiaodongChair, Scientific Advisory BrdS - Sale$126.46-4,84712,784,0000%-$612,937
DM
2019-05-20
BGNEHuang JaneCMO, HematologyS - Sale+OE$130.07-2,500271,621-1%-$325,168
D
2019-05-21
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$130.21-23,20052,338-31%-$3,020,860
2019-05-13
BGNEGlazer Donald W.DirS - Sale$125.11-15,0273,949,6780%-$1,880,028
D
2019-05-06
BGNELiang HowardCFO, Chief Strategy OfficerS - Sale+OE$130.01-1,80052,338-3%-$234,014
2019-05-01
BGNEWu XiaobinPres, GM ChinaS - Sale$124.53-5,9551,093,849-1%-$741,546
2019-05-01
BGNEOyler JohnCEOS - Sale$125.18-2,82464,546,0630%-$353,505
D
2019-04-08
BGNEHuang JaneCMO, HematologyS - Sale+OE$142.77-14,130271,621-5%-$2,017,315
2019-03-14
BGNEGlazer Donald W.DirS - Sale$136.10-14,9734,145,0290%-$2,037,825
DM
2019-03-07
BGNEHuang JaneCMO, HematologyS - Sale+OE$130.28-2,636271,621-1%-$343,426
M
2019-03-04
BGNEOyler JohnCEOS - Sale$151.73-25,49964,582,8750%-$3,868,938
DM
2018-12-17
BGNEPeterson Amy C.CMO, Immuno-oncologyS - Sale+OE$133.68-20,000194,569-9%-$2,673,536
2018-12-10
BGNEOyler JohnCEOS - Sale$135.78-4,13864,914,2620%-$561,863
2018-12-03
BGNEWang XiaodongDirS - Sale$152.41-5,00012,932,9800%-$762,061
M
2018-11-26
BGNEOyler JohnCEOS - Sale$143.66-29,19564,918,4000%-$4,194,035
D
2018-11-26
BGNEHuang JaneCMO, HematologyS - Sale+OE$139.58-3,000271,621-1%-$418,750
2018-11-19
BGNEWang XiaodongDirS - Sale$124.30-5,00013,087,9790%-$621,490
DM
2018-11-08
BGNEPeterson Amy C.CMO, Immuno-oncologyS - Sale+OE$120.20-40,000194,569-17%-$4,808,089
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top